AbbVie Inc (ABBV)

Receivables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 56,334,000 55,533,000 55,000,000 54,403,000 54,318,000 55,138,000 56,023,000 56,741,000 58,054,000 57,819,000 57,349,000 56,725,000 56,197,000 55,169,000 53,729,000 50,195,000 45,804,000 40,650,000 36,227,000 34,057,000
Receivables US$ in thousands
Receivables turnover

December 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $56,334,000K ÷ $—K
= —

Based on the provided data, AbbVie Inc's receivables turnover ratio is not available for any of the specified reporting dates ranging from March 31, 2020, to December 31, 2024. The receivables turnover ratio is a financial metric used to assess how efficiently a company is managing its accounts receivable in generating sales revenue.

In the absence of specific values for this ratio, it is challenging to evaluate AbbVie Inc's effectiveness in collecting outstanding receivables from its customers. A higher receivables turnover ratio generally indicates that the company is collecting payments from its customers quickly, which is a positive sign of liquidity and efficient credit management.

Without the actual figures for the receivables turnover ratio, it is not possible to draw detailed conclusions about AbbVie Inc's performance in this area. It may be advisable to seek additional financial information or historical data to conduct a more thorough analysis and gain insights into the company's receivables management practices.


See also:

AbbVie Inc Receivables Turnover (Quarterly Data)